<?xml version="1.0" encoding="UTF-8"?><experiments api-version="3" api-revision="091015" version="3.0" revision="091015" total="3" total-samples="88" total-assays="88"><experiment><id>239615</id><accession>E-GEOD-40176</accession><secondaryaccession>GSE40176</secondaryaccession><name>RNA sequencing of circulating tumour cells implicates WNT signaling in pancreatic cancer metastasis</name><releasedate>2012-08-17</releasedate><lastupdatedate>2014-06-02</lastupdatedate><organism>Homo sapiens</organism><organism>Mus musculus</organism><experimenttype>RNA-seq of coding RNA</experimenttype><description><id/><text>This SuperSeries is composed of the following subset Series: GSE40171: RNA sequencing of circulating tumour cells implicates WNT signaling in pancreatic cancer metastasis (mouse data) GSE40174: RNA sequencing of circulating tumour cells implicates WNT signaling in pancreatic cancer metastasis (human data) Refer to individual Series</text></description><provider><contact>Ben S. Wittner</contact><role>submitter</role><email>wittner.ben@mgh.harvard.edu</email></provider><bibliography><accession>22763454</accession><authors>Yu M, Ting DT, Stott SL, Wittner BS, Ozsolak F, Paul S, Ciciliano JC, Smas ME, Winokur D, Gilman AJ, Ulman MJ, Xega K, Contino G, Alagesan B, Brannigan BW, Milos PM, Ryan DP, Sequist LV, Bardeesy N, Ramaswamy S, Toner M, Maheswaran S, Haber DA</authors><title>RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis.</title><doi>10.1038/nature11217</doi></bibliography><samplecharacteristic><category>cell line</category><value>NB508</value></samplecharacteristic><samplecharacteristic><category>cell type</category><value>circulating tumor cell (CTC)</value><value>pancreatic cells</value></samplecharacteristic><samplecharacteristic><category>disease state</category><value>healthy</value><value>Pancreatic Cancer</value></samplecharacteristic><samplecharacteristic><category>donor</category><value>healthy donor 1</value><value>healthy donor 2</value><value>healthy donor 3</value><value>healthy donor 4</value><value>pancreatic cancer patient 11</value><value>pancreatic cancer patient 12</value><value>pancreatic cancer patient 16</value><value>pancreatic cancer patient 18</value><value>pancreatic cancer patient 19</value><value>pancreatic cancer patient 2</value><value>pancreatic cancer patient 20</value><value>pancreatic cancer patient 3</value><value>pancreatic cancer patient 4</value><value>pancreatic cancer patient 6</value><value>pancreatic cancer patient 7</value><value>pancreatic cancer patient 9</value></samplecharacteristic><samplecharacteristic><category>growth conditions</category><value>adherent</value><value>non-adherent 3-D sphere-forming</value></samplecharacteristic><samplecharacteristic><category>immunoprecipitate</category><value>EpCAM CTC-Chip</value><value>IgG CTC-Chip</value></samplecharacteristic><samplecharacteristic><category>mouse model</category><value>MPANC 10</value><value>MPANC 9</value></samplecharacteristic><samplecharacteristic><category>Organism</category><value>Homo sapiens</value><value>Mus musculus</value></samplecharacteristic><samplecharacteristic><category>organism part</category><value>ascites from pancreatic tumor</value><value>blood</value><value>primary pancreatic tumor</value></samplecharacteristic><samplecharacteristic><category>wnt2 expression</category><value>no</value><value>yes</value></samplecharacteristic><experimentalvariable><name>CELL TYPE</name><value>circulating tumor cell (CTC)</value><value>not specified</value><value>pancreatic cells</value></experimentalvariable><experimentalvariable><name>DISEASE STATE</name><value>healthy</value><value>not specified</value><value>Pancreatic Cancer</value></experimentalvariable><experimentalvariable><name>DONOR</name><value>healthy donor 1</value><value>healthy donor 2</value><value>healthy donor 3</value><value>healthy donor 4</value><value>not specified</value><value>pancreatic cancer patient 11</value><value>pancreatic cancer patient 12</value><value>pancreatic cancer patient 16</value><value>pancreatic cancer patient 18</value><value>pancreatic cancer patient 19</value><value>pancreatic cancer patient 2</value><value>pancreatic cancer patient 20</value><value>pancreatic cancer patient 3</value><value>pancreatic cancer patient 4</value><value>pancreatic cancer patient 6</value><value>pancreatic cancer patient 7</value><value>pancreatic cancer patient 9</value></experimentalvariable><experimentalvariable><name>GROWTH CONDITIONS</name><value>adherent</value><value>non-adherent 3-D sphere-forming</value><value>not specified</value></experimentalvariable><experimentalvariable><name>IMMUNOPRECIPITATE</name><value>EpCAM CTC-Chip</value><value>IgG CTC-Chip</value><value>not specified</value></experimentalvariable><experimentalvariable><name>MOUSE MODEL</name><value>MPANC 10</value><value>MPANC 9</value><value>not specified</value></experimentalvariable><experimentalvariable><name>ORGANISM</name><value>Homo sapiens</value><value>Mus musculus</value></experimentalvariable><experimentalvariable><name>ORGANISM PART</name><value>ascites from pancreatic tumor</value><value>blood</value><value>not specified</value><value>primary pancreatic tumor</value></experimentalvariable><experimentalvariable><name>WNT2 EXPRESSION</name><value>no</value><value>not specified</value><value>yes</value></experimentalvariable><protocol><id>636206</id><accession>P-GSE40176-3</accession></protocol><protocol><id>636207</id><accession>P-GSE40176-2</accession></protocol><protocol><id>636205</id><accession>P-GSE40176-1</accession></protocol></experiment><experiment><id>239617</id><accession>E-GEOD-40174</accession><secondaryaccession>SRP014893</secondaryaccession><secondaryaccession>GSE40174</secondaryaccession><name>RNA sequencing of circulating tumour cells implicates WNT signaling in pancreatic cancer metastasis (human data)</name><releasedate>2012-08-17</releasedate><lastupdatedate>2012-11-06</lastupdatedate><organism>Homo sapiens</organism><experimenttype>RNA-seq of coding RNA</experimenttype><description><id/><text>Circulating tumour cells (CTCs) shed into blood from primary cancers include putative precursors that initiate distal metastases. While these cells are extraordinarily rare, they may identify cellular pathways contributing to the blood-borne dissemination of cancer. Here, we adapted a microfluidic device for efficient capture of CTCs from an endogenous mouse pancreatic cancer model and subjected CTCs to single-molecule RNA sequencing, identifying Wnt2 as enriched in CTCs. Expression of Wnt2 in pancreatic cancer cells suppresses anoikis, enhances anchorage-independent sphere formation, and increases metastatic propensity in vivo. The effect of Wnt2 is correlated with fibronectin upregulation, and it is mediated in part through non-canonical Wnt signaling and suppressed by inhibition of the Map3k7 (Tak1) kinase, an integrator of Wnt, BMP and TGF-beta signaling. In humans, formation of non-adherent tumour spheres by pancreatic cancer cells is associated with upregulation of multiple Wnt genes, and pancreatic CTCs revealed significant enrichment for non-canonical Wnt signaling in 5 of 11 cases. Thus, molecular analysis of CTCs may identify novel therapeutic targets to prevent the distal spread of cancer. Expression profiling of circulating tumor cells in human pancreatic cancer patients support a hypothesis that WNT signaling plays a role in pancreatic cancer metastasis.</text></description><provider><contact>Sridhar Ramaswamy</contact><role/><email/></provider><provider><contact>Anna J Gilman</contact><role/><email/></provider><provider><contact>Matthew J Ulman</contact><role/><email/></provider><provider><contact>Paul Suchismita</contact><role/><email/></provider><provider><contact>Malgorzata E Smas</contact><role/><email/></provider><provider><contact>Shyamala Maheswaran</contact><role/><email/></provider><provider><contact>David P Ryan</contact><role/><email/></provider><provider><contact>Brian W Brannigan</contact><role/><email/></provider><provider><contact>Nabeel Bardeesy</contact><role/><email/></provider><provider><contact>Daniel A Haber</contact><role/><email/></provider><provider><contact>Brinda Alagesan</contact><role/><email/></provider><provider><contact>Ben S. Wittner</contact><role>submitter</role><email>wittner.ben@mgh.harvard.edu</email></provider><provider><contact>Patrice M Milos</contact><role/><email/></provider><provider><contact>Min Yu</contact><role/><email/></provider><provider><contact>David T Ting</contact><role/><email/></provider><provider><contact>Ben S Wittner</contact><role/><email/></provider><provider><contact>Fatih Ozsolak</contact><role/><email/></provider><provider><contact>Mehmet Toner</contact><role/><email/></provider><provider><contact>Daniel Winokur</contact><role/><email/></provider><provider><contact>Gianmarco Contino</contact><role/><email/></provider><provider><contact>Jordan C Ciciliano</contact><role/><email/></provider><provider><contact>Kristina Xega</contact><role/><email/></provider><provider><contact>Lecia V Sequist</contact><role/><email/></provider><provider><contact>Shannon L Stott</contact><role/><email/></provider><bibliography><accession>22763454</accession><authors>Yu M, Ting DT, Stott SL, Wittner BS, Ozsolak F, Paul S, Ciciliano JC, Smas ME, Winokur D, Gilman AJ, Ulman MJ, Xega K, Contino G, Alagesan B, Brannigan BW, Milos PM, Ryan DP, Sequist LV, Bardeesy N, Ramaswamy S, Toner M, Maheswaran S, Haber DA</authors><title>RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis.</title><doi>10.1038/nature11217</doi></bibliography><samplecharacteristic><category>cell type</category><value>circulating tumor cell (CTC)</value></samplecharacteristic><samplecharacteristic><category>disease state</category><value>healthy</value><value>Pancreatic Cancer</value></samplecharacteristic><samplecharacteristic><category>donor</category><value>healthy donor 1</value><value>healthy donor 2</value><value>healthy donor 3</value><value>healthy donor 4</value><value>pancreatic cancer patient 11</value><value>pancreatic cancer patient 12</value><value>pancreatic cancer patient 16</value><value>pancreatic cancer patient 18</value><value>pancreatic cancer patient 19</value><value>pancreatic cancer patient 2</value><value>pancreatic cancer patient 20</value><value>pancreatic cancer patient 3</value><value>pancreatic cancer patient 4</value><value>pancreatic cancer patient 6</value><value>pancreatic cancer patient 7</value><value>pancreatic cancer patient 9</value></samplecharacteristic><samplecharacteristic><category>immunoprecipitate</category><value>EpCAM CTC-Chip</value><value>IgG CTC-Chip</value></samplecharacteristic><samplecharacteristic><category>Organism</category><value>Homo sapiens</value></samplecharacteristic><samplecharacteristic><category>organism part</category><value>blood</value></samplecharacteristic><experimentalvariable><name>DISEASE STATE</name><value>healthy</value><value>Pancreatic Cancer</value></experimentalvariable><experimentalvariable><name>DONOR</name><value>healthy donor 1</value><value>healthy donor 2</value><value>healthy donor 3</value><value>healthy donor 4</value><value>pancreatic cancer patient 11</value><value>pancreatic cancer patient 12</value><value>pancreatic cancer patient 16</value><value>pancreatic cancer patient 18</value><value>pancreatic cancer patient 19</value><value>pancreatic cancer patient 2</value><value>pancreatic cancer patient 20</value><value>pancreatic cancer patient 3</value><value>pancreatic cancer patient 4</value><value>pancreatic cancer patient 6</value><value>pancreatic cancer patient 7</value><value>pancreatic cancer patient 9</value></experimentalvariable><experimentalvariable><name>IMMUNOPRECIPITATE</name><value>EpCAM CTC-Chip</value><value>IgG CTC-Chip</value></experimentalvariable><protocol><id>636217</id><accession>P-GSE40174-1</accession></protocol><protocol><id>636216</id><accession>P-GSE40174-2</accession></protocol><bioassaydatagroup><id/><name>scan</name><bioassaydatacubes>32</bioassaydatacubes><arraydesignprovider/><dataformat>scan</dataformat><bioassays>32</bioassays><isderived>0</isderived></bioassaydatagroup></experiment><experiment><id>239620</id><accession>E-GEOD-40171</accession><secondaryaccession>SRP014890</secondaryaccession><secondaryaccession>GSE40171</secondaryaccession><name>RNA sequencing of circulating tumour cells implicates WNT signaling in pancreatic cancer metastasis (mouse data)</name><releasedate>2012-08-17</releasedate><lastupdatedate>2012-11-06</lastupdatedate><organism>Mus musculus</organism><experimenttype>RNA-seq of coding RNA</experimenttype><description><id/><text>Circulating tumour cells (CTCs) shed into blood from primary cancers include putative precursors that initiate distal metastases. While these cells are extraordinarily rare, they may identify cellular pathways contributing to the blood-borne dissemination of cancer. Here, we adapted a microfluidic device for efficient capture of CTCs from an endogenous mouse pancreatic cancer model and subjected CTCs to single-molecule RNA sequencing, identifying Wnt2 as enriched in CTCs. Expression of Wnt2 in pancreatic cancer cells suppresses anoikis, enhances anchorage-independent sphere formation, and increases metastatic propensity in vivo. The effect of Wnt2 is correlated with fibronectin upregulation, and it is mediated in part through non-canonical Wnt signaling and suppressed by inhibition of the Map3k7 (Tak1) kinase, an integrator of Wnt, BMP and TGF-beta signaling. In humans, formation of non-adherent tumour spheres by pancreatic cancer cells is associated with upregulation of multiple Wnt genes, and pancreatic CTCs revealed significant enrichment for non-canonical Wnt signaling in 5 of 11 cases. Thus, molecular analysis of CTCs may identify novel therapeutic targets to prevent the distal spread of cancer. Expression profiling of primary tumor, circulating tumor cells and ascites in a mouse model of pancreatic cancer suggested WNT signaling plays a role in pancreatic cancer metastasis. Induction of Wnt2 signaling in mouse pancreatic NB508 cells supported the hypothesis.</text></description><provider><contact>Ben S Wittner</contact><role/><email/></provider><provider><contact>Brinda Alagesan</contact><role/><email/></provider><provider><contact>Daniel A Haber</contact><role/><email/></provider><provider><contact>Patrice M Milos</contact><role/><email/></provider><provider><contact>Shyamala Maheswaran</contact><role/><email/></provider><provider><contact>David P Ryan</contact><role/><email/></provider><provider><contact>David T Ting</contact><role/><email/></provider><provider><contact>Lecia V Sequist</contact><role/><email/></provider><provider><contact>Matthew J Ulman</contact><role/><email/></provider><provider><contact>Min Yu</contact><role/><email/></provider><provider><contact>Sridhar Ramaswamy</contact><role/><email/></provider><provider><contact>Mehmet Toner</contact><role/><email/></provider><provider><contact>Fatih Ozsolak</contact><role/><email/></provider><provider><contact>Ben S. Wittner</contact><role>submitter</role><email>wittner.ben@mgh.harvard.edu</email></provider><provider><contact>Jordan C Ciciliano</contact><role/><email/></provider><provider><contact>Malgorzata E Smas</contact><role/><email/></provider><provider><contact>Nabeel Bardeesy</contact><role/><email/></provider><provider><contact>Paul Suchismita</contact><role/><email/></provider><provider><contact>Anna J Gilman</contact><role/><email/></provider><provider><contact>Daniel Winokur</contact><role/><email/></provider><provider><contact>Shannon L Stott</contact><role/><email/></provider><provider><contact>Kristina Xega</contact><role/><email/></provider><provider><contact>Brian W Brannigan</contact><role/><email/></provider><provider><contact>Gianmarco Contino</contact><role/><email/></provider><bibliography><accession>22763454</accession><authors>Yu M, Ting DT, Stott SL, Wittner BS, Ozsolak F, Paul S, Ciciliano JC, Smas ME, Winokur D, Gilman AJ, Ulman MJ, Xega K, Contino G, Alagesan B, Brannigan BW, Milos PM, Ryan DP, Sequist LV, Bardeesy N, Ramaswamy S, Toner M, Maheswaran S, Haber DA</authors><title>RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis.</title><doi>10.1038/nature11217</doi></bibliography><samplecharacteristic><category>cell line</category><value>NB508</value></samplecharacteristic><samplecharacteristic><category>cell type</category><value>circulating tumor cell (CTC)</value><value>pancreatic cells</value></samplecharacteristic><samplecharacteristic><category>disease state</category><value>Pancreatic Cancer</value></samplecharacteristic><samplecharacteristic><category>growth conditions</category><value>adherent</value><value>non-adherent 3-D sphere-forming</value></samplecharacteristic><samplecharacteristic><category>immunoprecipitate</category><value>EpCAM CTC-Chip</value><value>IgG CTC-Chip</value></samplecharacteristic><samplecharacteristic><category>mouse model</category><value>MPANC 10</value><value>MPANC 9</value></samplecharacteristic><samplecharacteristic><category>Organism</category><value>Mus musculus</value></samplecharacteristic><samplecharacteristic><category>organism part</category><value>ascites from pancreatic tumor</value><value>blood</value><value>primary pancreatic tumor</value></samplecharacteristic><samplecharacteristic><category>wnt2 expression</category><value>no</value><value>yes</value></samplecharacteristic><experimentalvariable><name>CELL TYPE</name><value>circulating tumor cell (CTC)</value><value>not specified</value><value>pancreatic cells</value></experimentalvariable><experimentalvariable><name>GROWTH CONDITIONS</name><value>adherent</value><value>non-adherent 3-D sphere-forming</value><value>not specified</value></experimentalvariable><experimentalvariable><name>IMMUNOPRECIPITATE</name><value>EpCAM CTC-Chip</value><value>IgG CTC-Chip</value><value>not specified</value></experimentalvariable><experimentalvariable><name>MOUSE MODEL</name><value>MPANC 10</value><value>MPANC 9</value><value>not specified</value></experimentalvariable><experimentalvariable><name>ORGANISM PART</name><value>ascites from pancreatic tumor</value><value>blood</value><value>not specified</value><value>primary pancreatic tumor</value></experimentalvariable><experimentalvariable><name>WNT2 EXPRESSION</name><value>no</value><value>not specified</value><value>yes</value></experimentalvariable><protocol><id>636229</id><accession>P-GSE40171-1</accession></protocol><protocol><id>636228</id><accession>P-GSE40171-2</accession></protocol><bioassaydatagroup><id/><name>scan</name><bioassaydatacubes>12</bioassaydatacubes><arraydesignprovider/><dataformat>scan</dataformat><bioassays>12</bioassays><isderived>0</isderived></bioassaydatagroup></experiment></experiments>